Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome

European Journal of Surgical Oncology

Volumn 41, Issue 10, 2015, Pages 1300-1307

  Glatz, T ^a   Bronsert, P ^a   Schafer M ^a   Kulemann, B ^a   Marjanovic, G ^a   Sick, O ^a   Hopt, U T ^a   Zirlik, K ^a   Makowiec, F ^a   Hoeppner, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adenocarcinoma; Adjuvant chemotherapy; Esophageal cancer; Gastric cancer; Histopathological regression; Perioperative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PLATINUM COMPLEX; TAXOID;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHEMOSURGERY; CLASSIFICATION ALGORITHM; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRIC ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ESOPHAGEAL NEOPLASMS; FACTUAL DATABASE; KAPLAN MEIER METHOD; LOWER ESOPHAGUS SPHINCTER; MORTALITY; PATHOLOGY; POSTOPERATIVE PERIOD; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAPECITABINE; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DATABASES, FACTUAL; EPIRUBICIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TAXOIDS; TREATMENT OUTCOME;

EID: 84943816801     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.07.010     Document Type: Article

References (23)

1. E. Hiripi, L. Jansen, A. Gondos, and et al. Survival of stomach and esophagus cancer patients in Germany in the early 21st century Acta Oncol 51 2012 906 914
2. F. Makowiec, P. Baier, B. Kulemann, and et al. Improved long-term survival after esophagectomy for esophageal cancer: influence of epidemiologic shift and neoadjuvant therapy J Gastrointest Surg 17 2013 1193 1201
3. S. Law, D.L.W. Kwong, K.-F. Kwok, and et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy Ann Surg 238 2003 339 347
4. U. Ronellenfitsch, M. Schwarzbach, R. Hofheinz, and et al. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus Cochrane Database Syst Rev 5 2013 CD008107
5. B.-H. Xiong, Y. Cheng, L. Ma, and C.-Q. Zhang An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer Cancer Invest 32 2014 272 284
6. K.S. Naunheim, P. Petruska, T.S. Roy, and et al. Preoperative chemotherapy and radiotherapy for esophageal carcinoma J Thorac Cardiovasc Surg 103 1992 887 893
7. P. van Hagen, M.C.C.M. Hulshof, J.J.B. van Lanschot, and et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
8. J.S. Macdonald, S.R. Smalley, J. Benedetti, and et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
9. M. Sasako, S. Sakuramoto, H. Katai, and et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol 29 2011 4387 4393
10. D. Cunningham, W.H. Allum, S.P. Stenning, et al. MAGIC Trial Participants Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
11. M. Ychou, V. Boige, J.-P. Pignon, and et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 2011 1715 1721
12. P.C. Thuss-Patience, R.D. Hofheinz, D. Arnold, and et al. Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Ann Oncol 23 2012 2827 2834
13. S. Lorenzen, C. Pauligk, N. Homann, H. Schmalenberg, E. Jäger, and S.-E. Al-Batran Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer Br J Cancer 108 2013 519 526
14. D. Cunningham, N. Starling, S. Rao, and et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 2008 36 46
15. S. Lorenzen, M. Hentrich, C. Haberl, and et al. Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial Ann Oncol 18 2007 1673 1679
16. K. Becker, J.D. Mueller, C. Schulmacher, and et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy Cancer 98 2003 1521 1530
17. D. Dindo, N. Demartines, and P.-A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
18. S.Y. Moorcraft, E.C. Smyth, and D. Cunningham Adjuvant or neoadjuvant therapy for operable esophagogastric cancer? Gastric Cancer 18 2015 1 10
19. M. Sudarshan, T. Alcindor, S. Ades, and et al. Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma Ann Surg Oncol 22 2015 324 330
20. C. Schuhmacher, S. Gretschel, F. Lordick, and et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954 J Clin Oncol 28 2010 5210 5218
21. A. Mirza, S. Pritchard, and I. Welch The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas Int J Surg Oncol 2013 2013 781742
22. T. Alcindor, L.E. Ferri, V. Marcus, and et al. Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome Med Oncol 30 2013 377
23. A.M. Francis, B. Sepesi, A.M. Correa, and et al. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma Ann Surg 258 2013 500 507